Changes in the Global Obesity Treatment Market

1 Min Read

The obesity treatment market is poised to undergo significant shifts from the balance of products used that are drugs versus devices.   While a significant volume of the obesity market is drugs, the drug market potential has yet to be tapped to any significant extent. However, recent FDA moves to reconsider obesity drugs that it previously held up has given the obesity drug market much new life.

Below is illustrated the global market for obesity drugs and devices in both 2011 and 2016. 

The obesity treatment market is poised to undergo significant shifts from the balance of products used that are drugs versus devices.   While a significant volume of the obesity market is drugs, the drug market potential has yet to be tapped to any significant extent. However, recent FDA moves to reconsider obesity drugs that it previously held up has given the obesity drug market much new life.

Below is illustrated the global market for obesity drugs and devices in both 2011 and 2016. 

Source: MedMarket Diligence, LLC; Report #S835, “Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019.”

     

TAGGED:
Share This Article
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Exit mobile version